Literature DB >> 22344669

Induction of holomycin production and complex metabolic changes by the argR mutation in Streptomyces clavuligerus NP1.

Hua Yin1, Sihai Xiang, Jianting Zheng, Keqiang Fan, Tingting Yu, Xu Yang, Yanfeng Peng, Haibin Wang, Deqin Feng, Yuanming Luo, Hua Bai, Keqian Yang.   

Abstract

In bacteria, arginine biosynthesis is tightly regulated by a universally conserved regulator, ArgR, which regulates the expression of arginine biosynthetic genes, as well as other important genes. Disruption of argR in Streptomyces clavuligerus NP1 resulted in complex phenotypic changes in growth and antibiotic production levels. To understand the metabolic changes underlying the phenotypes, comparative proteomic studies were carried out between NP1 and its argR disruption mutant (designated CZR). In CZR, enzymes involved in holomycin biosynthesis were overexpressed; this is consistent with its holomycin overproduction phenotype. The effects on clavulanic acid (CA) biosynthesis are more complex. Several proteins from the CA cluster were moderately overexpressed, whereas several proteins from the 5S clavam biosynthetic cluster and from the paralog cluster of CA and 5S clavam biosynthesis were severely downregulated. Obvious changes were also detected in primary metabolism, which are mainly reflected in the altered expression levels of proteins involved in acetyl-coenzyme A (CoA) and cysteine biosynthesis. Since acetyl-CoA and cysteine are precursors for holomycin synthesis, overexpression of these proteins is consistent with the holomycin overproduction phenotype. The complex interplay between primary and secondary metabolism and between secondary metabolic pathways were revealed by these analyses, and the insights will guide further efforts to improve production levels of CA and holomycin in S. clavuligerus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22344669      PMCID: PMC3346449          DOI: 10.1128/AEM.07699-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  55 in total

1.  Enzymes catalyzing the early steps of clavulanic acid biosynthesis are encoded by two sets of paralogous genes in Streptomyces clavuligerus.

Authors:  S E Jensen; K J Elder; K A Aidoo; A S Paradkar
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Role of σ-factor (orf21) in clavulanic acid production in Streptomyces clavuligerus NRRL3585.

Authors:  Hum Nath Jnawali; Kwangkyoung Liou; Jae Kyung Sohng
Journal:  Microbiol Res       Date:  2010-09-25       Impact factor: 5.415

3.  Identification of the gene cluster for the dithiolopyrrolone antibiotic holomycin in Streptomyces clavuligerus.

Authors:  Bo Li; Christopher T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

4.  Antimicrobial properties and mode of action of the pyrrothine holomycin.

Authors:  B Oliva; A O'Neill; J M Wilson; P J O'Hanlon; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  Applications of gene replacement technology to Streptomyces clavuligerus strain development for clavulanic acid production.

Authors:  A S Paradkar; R H Mosher; C Anders; A Griffin; J Griffin; C Hughes; P Greaves; B Barton; S E Jensen
Journal:  Appl Environ Microbiol       Date:  2001-05       Impact factor: 4.792

6.  Characterization of the tunicamycin gene cluster unveiling unique steps involved in its biosynthesis.

Authors:  Wenqing Chen; Dongjing Qu; Lipeng Zhai; Meifeng Tao; Yemin Wang; Shuangjun Lin; Neil P J Price; Zixin Deng
Journal:  Protein Cell       Date:  2010-12-09       Impact factor: 14.870

7.  Characterization of DNA-binding sequences for CcaR in the cephamycin-clavulanic acid supercluster of Streptomyces clavuligerus.

Authors:  I Santamarta; M T López-García; A Kurt; N Nárdiz; R Alvarez-Álvarez; R Pérez-Redondo; J F Martín; P Liras
Journal:  Mol Microbiol       Date:  2011-07-20       Impact factor: 3.501

8.  Characterization and expression of the arginine biosynthesis gene cluster of Streptomyces clavuligerus.

Authors:  A Rodríguez-García; A de la Fuente; R Pérez-Redondo; J F Martín; P Liras
Journal:  J Mol Microbiol Biotechnol       Date:  2000-10

9.  Streptomyces clavuligerus HlmI is an intramolecular disulfide-forming dithiol oxidase in holomycin biosynthesis.

Authors:  Bo Li; Christopher T Walsh
Journal:  Biochemistry       Date:  2011-05-06       Impact factor: 3.162

10.  A rhodanese-like protein is highly overrepresented in the mutant S. clavuligerus oppA2::aph: effect on holomycin and other secondary metabolites production.

Authors:  Nuria Nárdiz; Irene Santamarta; Luis M Lorenzana; Juan F Martín; Paloma Liras
Journal:  Microb Biotechnol       Date:  2010-11-02       Impact factor: 5.813

View more
  5 in total

1.  Enhancement of FK506 production by engineering secondary pathways of Streptomyces tsukubaensis and exogenous feeding strategies.

Authors:  Di Huang; Menglei Xia; Shanshan Li; Jianping Wen; Xiaoqiang Jia
Journal:  J Ind Microbiol Biotechnol       Date:  2013-06-19       Impact factor: 3.346

Review 2.  Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics.

Authors:  Bo Li; Walter J Wever; Christopher T Walsh; Albert A Bowers
Journal:  Nat Prod Rep       Date:  2014-07       Impact factor: 13.423

3.  Genome mining reveals unlocked bioactive potential of marine Gram-negative bacteria.

Authors:  Henrique Machado; Eva C Sonnenschein; Jette Melchiorsen; Lone Gram
Journal:  BMC Genomics       Date:  2015-03-07       Impact factor: 3.969

4.  Enhancing effect of lysine combined with other compounds on cephamycin C production in Streptomyces clavuligerus.

Authors:  Carla A Leite; André P Cavallieri; Maria L G C Araujo
Journal:  BMC Microbiol       Date:  2013-12-20       Impact factor: 3.605

Review 5.  Dithiolopyrrolone natural products: isolation, synthesis and biosynthesis.

Authors:  Zhiwei Qin; Sheng Huang; Yi Yu; Hai Deng
Journal:  Mar Drugs       Date:  2013-10-17       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.